Advertisement

Vitiligo pp 41-51 | Cite as

Vitiligo/nonsegmental Vitiligo Including Acrofacial and Universalis

  • Thierry Passeron
  • Jean-Paul Ortonne
  • Prasad Kumarasinghe
  • Alain TaïebEmail author
Chapter

Abstract

Based on the VGICC classification, vitiligo/NSV, a consensus umbrella term for all forms of generalized vitiligo, is meant to describe different clinical subtypes of vitiligo that are all clearly distinct from SV including acrofacial, generalized, mucosal (multifocal), and universal. According to the VETF definition, generalized vitiligo is characterized by asymptomatic well-circumscribed milky-white macules involving both sides of the body with usually a symmetrical pattern. In acrofacial vitiligo (AFV), the involved sites are by definition limited to the face, head, hands, and feet with typically depigmentation of the distal fingers and facial orifices. Vitiligo universalisis a rapidly progressive form of the disease, which needs a more in-depth investigation especially for associated autoimmunity.

Notes

Acknowledgements

Dr. Prasad Kumarasinghe is grateful to Prof. Roy Chan, Medical Director, and Dr. Goh Boon Kee, Consultant Dermatologist, National Skin Centre, Singapore, for providing some of the VU photographs.

References

  1. 1.
    Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Boniface K, Cario-André M, Prey S, Ballanger F, Boralevi F, Jouary T, Mossalayi D, Taieb A. Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol. 2012;167:490–5.CrossRefGoogle Scholar
  2. 2.
    Le Poole C. Vitiligo vulgaris. In: Nordlund J, editor. The pigmentary system. Malden, MA: Blackwell Publishing; 2006. p. 551–98.Google Scholar
  3. 3.
    Liu JB, Li M, Yang S, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol. 2005;30:327–31.CrossRefGoogle Scholar
  4. 4.
    Zhang XJ, Liu JB, Gui JP, et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol. 2004;51:383–90.CrossRefGoogle Scholar
  5. 5.
    Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. In: Parrish JA, Fitzpatrick TB, editors. Monographs in topics in dermatology. New York, NY: Plenum Press; 1983. p. 1–683.Google Scholar
  6. 6.
    Ortonne JP. Vitiligo and other disorders of hypopigmentation. In: Bolognia J, Jorizzo JL, Rapini RP, editors. Dermatology. New York, NY: Mosby; 2007. p. 913–38.Google Scholar
  7. 7.
    Gan EY, Cario-André M, Pain C, Goussot JF, Taïeb A, Seneschal J, Ezzedine K. Follicular vitiligo: a report of 8 cases. J Am Acad Dermatol. 2016;74:1178–84.CrossRefGoogle Scholar
  8. 8.
    Chun WH, Hann SK. The progression of nonsegmental vitiligo: clinical analysis of 318 patients. Int J Dermatol. 1997;36:908–10.CrossRefGoogle Scholar
  9. 9.
    Fargnoli MC, Bolognia JL. Pentachrome vitiligo. J Am Acad Dermatol. 1995;33:853–6.CrossRefGoogle Scholar
  10. 10.
    Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149–56.CrossRefGoogle Scholar
  11. 11.
    Ivker R, Goldaber M, Buchness MR. Blue vitiligo. J Am Acad Dermatol. 1994;30:829–31.CrossRefGoogle Scholar
  12. 12.
    Mchepange UO, Gao XH, Liu YY, Liu YB, Ma L, Zhang L, Chen HD. Vitiligo in North-Eastern China: an association between mucosal and acrofacial lesions. Acta Derm Venereol. 2010;90:136–40.CrossRefGoogle Scholar
  13. 13.
    Silva de Castro CC, do Nascimento LM, Olandoski M, Mira MT. A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population. J Dermatol Sci. 2012;65:63–7.CrossRefGoogle Scholar
  14. 14.
    Agarwal S, Ojha A, Gupta S. Profile of vitiligo in Kumaun region of Uttarakhand, India. Indian J Dermatol. 2014;59:209.  https://doi.org/10.4103/0019-5154.127706.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Attili VR, Attili SK. Acral vitiligo and lichen sclerosus - association or a distinct pattern?: a clinical and histopathological review of 15 cases. Indian J Dermatol. 2015;60:519.CrossRefGoogle Scholar
  16. 16.
    Shah AS, Supapannachart N, Nordlund JJ. Acquired hypomelanotic disorders. In: Levine N, editor. Pigmentation and pigmentary disorders. Boca Raton, FL: CRS Press; 1993. p. 337–51.Google Scholar
  17. 17.
    Song MS, Hann SK, Ahn PS, et al. Clinical study of vitiligo: comparative study of Type A and Type B vitiligo. Ann Dermatol. 1994;6:22–30.CrossRefGoogle Scholar
  18. 18.
    Tan WP, Goh BK, Tee SI, Kumarasinghe SPW. Clinical Profile of vitiligo in Singapore. 2nd Meeting of the Asian Society for Pigment Cell Research, July 2007, Singapore. Pigment Cell Res. 2007;20:253.. (abstract).Google Scholar
  19. 19.
    Hann SK, Nordlund JJ. Clinical features of generalized vitiligo. In: Hann S-K, Nordlund JJ, editors. Vitiligo. Oxford: Blackwell; 2000. p. 81–8.CrossRefGoogle Scholar
  20. 20.
    Aydogan K, Turan OF, Onart S, et al. Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol. 2006;31:110–3.CrossRefGoogle Scholar
  21. 21.
    Pan JY, Goh BK, Theng C, Kumarasinghe SPW. Vitiligo as a reaction to topical treatment with diphencyprone. 2nd Meeting of the Asian Society for Pigment Cell Research, July 2007, Singapore. Pigment Cell Res. 2007;20:247.. (abstract).Google Scholar
  22. 22.
    Dogra S, Kumar B. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration and melanocyte reservoir. Dermatol Online J. 2005;11:30.PubMedGoogle Scholar
  23. 23.
    Husain I, Vijayan E, Ramaiah A, et al. Demonstration of tyrosinase in the vitiligo skin of human beings by a sensitive fluorometric method as well as by 14C(U) L tyrosine incorporation into melanin. J Invest Dermatol. 1982;78:243–52.CrossRefGoogle Scholar
  24. 24.
    Tobin DJ, Swanson NN, Pittlekow MR, et al. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol. 2000;191:407–16.CrossRefGoogle Scholar
  25. 25.
    Naughton GK, Eisenger M, Bystryn JC. Antibodies to normal human melanocytes in vitiligo. J Exp Med. 1983;158:246–51.CrossRefGoogle Scholar
  26. 26.
    Kumarasinghe SPW. An optimistic approach to management of vitiligo. Ceylon Med J. 1995;40:94–6.PubMedGoogle Scholar
  27. 27.
    Schallreuter KU, Behrens-Williams S, Khaliq TP, et al. Increased epidermal functioning wildtype p53 expression in vitiligo. Exp Dermatol. 2003;12:268–77.CrossRefGoogle Scholar
  28. 28.
    Mattoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Thierry Passeron
    • 1
  • Jean-Paul Ortonne
    • 2
  • Prasad Kumarasinghe
    • 3
  • Alain Taïeb
    • 4
    Email author
  1. 1.Department of DermatologyUniversity Hospital of NiceNiceFrance
  2. 2.Department of DermatologyArchet-2 hospitalNiceFrance
  3. 3.Department of DermatologyRoyal Perth HospitalPerthAustralia
  4. 4.Service de DermatologieHôpital St André, CHU de BordeauxBordeauxFrance

Personalised recommendations